Cronos Group Inc banner

Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 3.39 CAD -2.59%
Market Cap: CA$1.3B

Cronos Group Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cronos Group Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Cronos Group Inc
TSX:CRON
Research & Development
-$4.4m
CAGR 3-Years
30%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Research & Development
-$629m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Canopy Growth Corp
TSX:WEED
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
Research & Development
-CA$478k
CAGR 3-Years
44%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Research & Development
-$105.2m
CAGR 3-Years
-41%
CAGR 5-Years
-61%
CAGR 10-Years
-152%
K
Knight Therapeutics Inc
TSX:GUD
Research & Development
-CA$27.1m
CAGR 3-Years
-24%
CAGR 5-Years
-23%
CAGR 10-Years
-26%
No Stocks Found

Cronos Group Inc
Glance View

Market Cap
1.3B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.91 CAD
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Cronos Group Inc's Research & Development?
Research & Development
-4.4m USD

Based on the financial report for Dec 31, 2025, Cronos Group Inc's Research & Development amounts to -4.4m USD.

What is Cronos Group Inc's Research & Development growth rate?
Research & Development CAGR 5Y
26%

Over the last year, the Research & Development growth was -5%. The average annual Research & Development growth rates for Cronos Group Inc have been 30% over the past three years , 26% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett